GAMIDA CELL LTD (GMDA)
IL0011552663 - Common Stock
GAMIDA CELL LTD
NASDAQ:GMDA (4/5/2024, 7:00:00 PM)
After market: 0.032 0 (-2.14%)0.0327
-0.01 (-18.25%)
Company Profile
Gamida Cell Ltd. engages in the development of cell therapies to cure blood cancer and rare serious hematologic diseases. The firm develops cell therapies that are designed to cure cancer and rare, serious hematologic diseases. The firm is leveraging its nicotinamide (NAM)-based cell expansion technology toto expand multiple cell types including stem cells and natural killer (NK) cells while maintaining their original phenotype and potency. The following are the Company's clinical pipeline products: Omidubicel dedicated to hematologic malignancies and severe aplastic anemia; GDA-201 dedicated for treatment of non-Hodgkin Lymphoma; GDA-301, GDA-401, GDA-501 dedicated to treatment of solid tumors, GDA-601 dedicated to multiple myeloma.
Company Info
GAMIDA CELL LTD
PO Box 34670
JERUSALEM 95484
P: 97226595666
CEO: Julian Adams
Employees: 143
Website: https://www.gamida-cell.com/
GMDA News
22 days ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on FridayIt's time to dive into all of the biggest pre-market stock movers that traders will want to keep an eye on Friday morning!
25 days ago - Aquestive Therapeutics, Inc.Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech ExecutiveAppoints Abigail “Abbey” Jenkins, a veteran biotech executive with over 20 years of experience in commercial leadership, to Board of Directors
a month ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on ThursdayPre-market stock movers are a hot topic on Thursday as we check out all of the biggest stories moving shares this morning!
a month ago - InvestorPlaceTrump Media (DJT) Stock Jumps 18% in Second Trading DayTrump Media & Technology stock is on the rise Wednesday as shares of DJT continue to rally for the second day after going public.
a month ago - InvestorPlaceGMDA Stock Earnings: Gamida Cell Beats EPS, Beats Revenue for Q4 2023GMDA stock results show that Gamida Cell beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.
a month ago - BusinessInsiderGMDA Stock Earnings: Gamida Cell Beats EPS, Beats Revenue for Q4 2023InvestorPlace - Stock Market News, Stock Advice & Trading Tips Gamida Cell (NASDAQ:GMDA) just reported results for the fourth quarter of 2023....
GMDA Twits
Here you can normally see the latest stock twits on GMDA, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
